摘要
目的:了解武汉地区医院抗肿瘤分子靶向治疗药物的使用情况与特点。方法:对武汉地区32家医院2009～2011年抗肿瘤分子靶向治疗药物的应用品种、销售金额、用药频度(DDDs)及日均费用(DDC)等进行回顾性统计和分析。结果:武汉地区抗肿瘤分子靶向治疗药物销售金额与DDDs呈逐年增长趋势,DDC相对稳定。结论:2009～2011年武汉地区抗肿瘤分子靶向治疗药物应用状况和发展趋势较为合理。
Objective：To investigate the utilization and characteristics of antineoplastic for molecular target therapy in hospitals of Wuhan.Methods：The utilization data of antineoplastic for molecular target therapy were statistically analyzed in 32 hospitals of Wuhan during 2009-2011 in terms of category,consumption sum,DDDs,and DDC.Results：The consumption sum and DDDs of antineoplastic for molecular target therapy were increasing year by year,and the DDC leveled off.Conclusion：The utilization of antineoplastic for molecular target therapy is reasonable.
出处
《药物流行病学杂志》
CAS
2013年第1期32-34,共3页
Chinese Journal of Pharmacoepidemiology
